Protein Design Space is an independent scientific webspace for enzyme discovery, protein engineering, biocatalysis, green chemistry, computational design, patent intelligence and scalable biomanufacturing.
The workflow generalises the enzyme-development sequence described in the supplied biocatalysis brochure: identify the enzyme, engineer it, choose an expression system, produce the catalyst, design the reaction, validate the process and translate it to scale. It is expanded here to begin with biological diversity and end with sustainability and IP decisions.
For beginners, AI-enabled protein engineering can be understood as a way to combine evolutionary diversity, protein structure and machine-learning predictions to decide which residues and variants are most worth testing. The goal is to move from thousands or millions of possible mutations to a smaller, information-rich experimental set.
Choose the property you want to improve: activity, selectivity, thermostability, solvent tolerance, expression, substrate range or another measurable function. AI is most useful when the experimental objective is clear.
Use homologues from databases or metagenomic sources. Sequence diversity reveals what nature has already explored and provides the raw material for conservation and consensus analysis.
Build a multiple-sequence alignment and look for conserved, variable and consensus residues. Consensus substitutions can be useful starting points, especially for stability, but should be interpreted in structural context.
Use an experimental or predicted structure to identify catalytic residues, ligand-contacting positions, interfaces, flexible regions and substrate-access tunnels. This separates important functional positions from positions that may tolerate change.
Combine conservation, structure, active-site distance, tunnel analysis and engineering tools such as HotSpot Wizard or FireProt. The output should be a shortlist of positions rather than a random whole-protein library.
Protein language models and structure-aware models can score whether substitutions look compatible with natural sequence patterns or a given 3D backbone. Treat these scores as prioritisation signals, not proof of improved function.
Structure-conditioned design approaches such as ProteinMPNN-style methods can suggest amino acids compatible with a backbone, while ligand-aware approaches can focus design around a substrate or cofactor environment.
Select a manageable set of variants that represents different hypotheses: consensus changes, active-site changes, tunnel mutations, stability mutations and AI-ranked substitutions. Test the same measurable property across all variants.
Use measured activity, stability, expression or selectivity to refine the next round. Even a small dataset can reveal which design assumptions were useful and which regions of sequence space deserve deeper exploration.
This is a simple hypothetical example to show the logic. Imagine your enzyme has Methionine at position 148 (M148), and you want to know whether this position is worth engineering.
Examples below are shown as technology case studies.
ω-Transaminase catalysis is a classic example of engineering an enzyme for a demanding chiral-amine transformation.
A ketoreductase / alcohol-dehydrogenase route demonstrates how protein engineering can replace a sensitive stoichiometric chiral-reduction reagent.
The lipase-enabled pregabalin manufacturing as an example of improved yield, lower process mass intensity and lower energy demand.
The same workflow applies to industrial enzymes, food biocatalysis, specialty chemicals, environmental enzymes, alternative proteins and precision-fermented products: discover diversity, engineer function, build the expression system, validate application and scale.
Protein Design Space is intentionally application-agnostic.
The specific pharmaceutical process-redesign examples. These are useful benchmarks for waste reduction even when the redesigned route is not necessarily enzyme-based.
| API | Example sponsor | Reported waste decrease | How it informs protein design |
|---|---|---|---|
| Sertraline HCl | Pfizer / Zoloft | 92% | Shows the scale of process simplification worth targeting. |
| Sildenafil citrate | Pfizer / Viagra | 93% | Benchmark for solvent, reagent and unit-operation reduction. |
| Celecoxib | Pfizer / Celebrex | 69% | Reminds enzyme projects to compare against redesigned chemistry, not legacy chemistry only. |
| Pregabalin | Pfizer / Lyrica | 80% | Connects catalytic selectivity to large reductions in process waste. |
| Quinapril HCl | Pfizer / Accupril | 80% | Useful benchmark for route-level sustainability. |
| Sitagliptin | Merck / Januvia | 80% | Illustrates how enzyme engineering can become manufacturing innovation. |
| Paclitaxel | BMS / Taxol | >90% | Highlights the value of route redesign for complex molecules. |
| Nevirapine | Medicines for All Institute | 93% | Demonstrates the importance of whole-route optimisation. |
| Ganciclovir | Roche Colorado Corp. | 89% | Another benchmark for material-efficiency improvement. |
These resources are grouped by the scientific task they support: learning, sequence discovery, structure, mutation design, channel analysis, molecular visualisation and patent intelligence. Availability and licensing can vary, so check provider terms before commercial use.
Research and news collection covering protein-engineering methods and applications.
Open Nature topic ↗Perspective linking protein-engineering decisions with industrial biocatalytic process development.
Open DOI ↗Foundational review covering directed-evolution concepts, library generation and selection for improved protein function.
Open DOI ↗Review of semi-rational strategies that combine sequence, structure and predictive design.
Open DOI ↗Academic research resource for enzyme engineering, biocatalysis and protein–function relationships.
Open resource ↗Start with homologues, annotations and sequence-level physicochemical profiling before narrowing the design space.
Search homologous protein sequences and expand a known enzyme into a broader diversity set.
Open BLAST ↗Protein sequences, functional annotations, catalytic information, domains and cross-references.
Open UniProt ↗Plot amino-acid-scale properties along a protein sequence, including hydrophobicity and other residue-based profiles.
Open ProtScale ↗Align homologous protein sequences to identify conserved and variable positions across a protein family.
Open Clustal Omega ↗Fast and flexible multiple-sequence alignment, useful for large and diverse protein families.
Open MAFFT ↗Multiple-sequence comparison for conservation analysis and mutation-position selection.
Open MUSCLE ↗Consistency-based sequence alignment with options for integrating different alignment evidence.
Open T-Coffee ↗Use experimental structures where available, homology models where suitable, and predicted structures to guide engineering hypotheses.
Search predicted protein structures for structure-guided analysis and comparison.
Open AlphaFold DB ↗Template-based protein structure modelling with model-quality assessment.
Open SWISS-MODEL ↗Experimental macromolecular structures for templates, active-site comparison and structural benchmarking.
Open RCSB PDB ↗Protein modelling and design ecosystem used for structure prediction, docking, redesign and de novo protein design.
Open Rosetta ↗Protein structure and function prediction from sequence using threading and iterative structure assembly.
Open I-TASSER ↗Sensitive profile–profile comparison for remote-homology detection and structure-template discovery.
Open HHpred ↗Use structure and sequence information to identify candidate engineering positions, then prioritise mutations for stability, activity or altered specificity.
Web-based protein-engineering workflow for identifying mutagenesis hotspots using structural, functional and evolutionary information.
Open HotSpot Wizard ↗Protein stability design using structural and evolutionary information to propose stabilising mutations.
Open FireProt ↗Especially valuable when activity, selectivity or solvent tolerance may depend on access tunnels and internal cavities rather than only catalytic residues.
Analyse access tunnels and pathways connecting buried protein regions with bulk solvent.
Open CAVER ↗Methods and resources for analysing channels, pores and tunnels in biomacromolecular structures.
Open ChannelsDB 2.0 ↗Use these tools to examine structures, map mutations, view ligands and interfaces, and analyse molecular-dynamics trajectories.
Structure visualisation for active sites, residue mapping, ligand inspection and scientific figures.
Open PyMOL ↗Molecular visualisation and analysis, widely used with molecular-dynamics trajectories.
Open VMD ↗Use patent searching before and during engineering to understand technology ownership, claimed sequence families and potentially crowded mutation space.
Search patents and scholarly literature, build patent landscapes and investigate technology ownership.
Open Lens ↗Search biological sequences disclosed in patents and connect protein sequence space to patent documents.
Open PatSeq Finder ↗Industrial Biotechnology & Biomanufacturing Scientist
PhD molecular and cellular biologist with 19+ years of industrial biotechnology R&D experience spanning industrial enzymes, protein engineering, recombinant proteins and biologics, precision fermentation, downstream processing, analytics, scale-up and commercial translation.
Protein and enzyme variant discovery, rational design, directed evolution, screening and global application programs.
Fermentation, downstream processing, analytics, process troubleshooting and manufacturability.
Built an integrated 1–100 L mycoprotein pilot platform and developed a commercial-scale manufacturing concept.
Multidisciplinary development across therapeutic proteins, peptides, vaccines, antibodies and microbial enzyme programs.
Catalytic activity alone is not enough. A useful industrial biocatalyst must survive and perform in the actual process window.
A strong protein-design programme can combine sequence and structure analysis with patent intelligence: identify claimed sequence families and mutation positions, then explore genuinely distinct scaffolds, underused structural regions and alternative process architectures.
Protein engineering, enzyme discovery, biocatalysis, green chemistry, patent landscapes, technical reviews and industrial biotechnology.